All Stories

  1. Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR
  2. Three-Dimensional Cultures for Collecting CNS and PNS Glial Secreted Factors, Vesicles and Scaffolds Free of Animal Serum Components
  3. The Biological Role and Translational Implications of the Long Non-Coding RNA GAS5 in Breast Cancer
  4. Droplet Digital PCR Development To Quantify the DNA Meth-Ylation Levels of SEPT9 and SHOX2 in Plasma From Patients With Head and Neck Squamous Cell Carcinoma
  5. Lasp1 Expression Is Implicated in Embryonic Development of Zebrafish
  6. Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma
  7. Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib
  8. Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer
  9. H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis
  10. DNA methylation variations in familial female and male breast cancer
  11. MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study
  12. miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study
  13. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy
  14. Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib
  15. Analysis of a nanoparticle‑enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis
  16. Functional Role of microRNA-23b-3p Cancer Biology tumour suppressor miR Exosome miR
  17. Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers
  18. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
  19. miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease
  20. Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes
  21. Environment and bladder cancer: molecular analysis by interaction networks
  22. Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells
  23. Biological Function of MicroRNA193a-3p in Health and Disease
  24. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
  25. Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis
  26. Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells
  27. De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay
  28. Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
  29. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC
  30. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression
  31. The Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular Migration
  32. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells
  33. Proteomic Identification of LASP-1 Down-regulation After RNAi Urokinase Silencing in Human Hepatocellular Carcinoma Cells
  34. RET/PTC1-Driven Neoplastic Transformation and Proinvasive Phenotype of Human Thyrocytes Involve Met Induction and β-Catenin Nuclear Translocation
  35. RNA Interference against Urokinase in Hepatocellular Carcinoma Xenografts in Nude Mice
  36. Matrix Assembly Induction and Cell Migration and Invasion Inhibition by a 13-Amino Acid Fibronectin Peptide
  37. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells
  38. Induction of Fibronectin mRNA by Urokinase- and Tissue-Type Plasminogen Activator in Human Skin Fibroblasts: Differential Role of u-PA and t-PA at the Fibronectin Protein Level
  39. Gene Response of Human Skin Fibroblasts to Urokinase-and Tissue-Type Plasminogen Activators
  40. Phosphorylation of human plasminogen activators and plasminogen
  41. Urokinase-Type and Tissue-Type Plasminogen Activators as Growth Factors of Human Fibroblasts
  42. RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: Molecular markers for hepatocellular carcinoma
  43. Interaction of tissue-type plasminogen activator with fibronectin and fibronectin fragments
  44. Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients
  45. Characterisation of fibronectin fragments and plasminogen activators released by RSV-transformed cells
  46. A rapid and highly sensitive solid-phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody
  47. Tissue type plasminogen activator, but not urokinase, exerts transformation-enhancing activity
  48. Monoclonal antibody against theN-terminal end of human plasma fibronectin
  49. Transformation-enhancing activity in plasma of tumor patients: Relationship with fibronectin fragments
  50. Transformation-enhancing activity of gelatin-binding fragments of fibronectin.
  51. Inhibition of rous sarcoma-virus-induced transformation by proteins involved in blood coagulation